Jansky–Bielschowsky disease

Jansky–Bielschowsky disease is a rare, neurodegenerative disorder characterized by progressive vision loss, intellectual disability, and motor dysfunction. It is a variant of Batten disease, which is a group of disorders known as neuronal ceroid lipofuscinoses (NCLs).

Symptoms

The symptoms of Jansky–Bielschowsky disease typically begin between ages 5 and 10. The first signs of the disease are usually vision problems, including blindness, due to degeneration of the retina. This is followed by intellectual disability, loss of motor skills, and seizures.

Causes

Jansky–Bielschowsky disease is caused by mutations in the CLN3 gene. This gene provides instructions for making a protein that is found in many tissues and organs, but its function is not well understood. Mutations in the CLN3 gene lead to a shortage (deficiency) of the CLN3 protein, which disrupts the normal functioning of cells, particularly cells in the brain and retina.

Diagnosis

Diagnosis of Jansky–Bielschowsky disease is based on the presence of characteristic symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. These tests may include blood tests, urine tests, skin or tissue sampling, and detailed neurological and ophthalmological evaluations.

Treatment

There is currently no cure for Jansky–Bielschowsky disease. Treatment is directed toward the specific symptoms that are apparent in each individual. Such treatment may require the coordinated efforts of a team of specialists, including pediatricians, neurologists, ophthalmologists, and other healthcare professionals.

Prognosis

The prognosis for individuals with Jansky–Bielschowsky disease is poor. Most individuals with the disease live into their teens or early twenties.

See also

• Batten disease
• Neuronal ceroid lipofuscinoses
• CLN3

Jansky–Bielschowsky disease Resources
Latest articles Most recent articles Ongoing trials	Wikipedia